Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Iranian Journal of Pharmaceutical Research : IJPR|November 20, 2013
Study of compressibility properties of yogurt powder in order to prepare a complementary formulationAbdolhossein Moghbel, Hamideh Abbaspour
Bioimpacts : BI|March 31, 2025
Effectiveness of dolutegravir in moderate severity COVID-19 patients: A single-center, randomized, double-blind, placebo-controlled trialHamideh Abbaspour Kasgari, Siavash Moradi, Ahmad Alikhani, et al.
Clinical Case Reports|October 3, 2022
Brucella pleurisy: An extremely rare complication of brucellosisAhmad Alikhani, Hamideh Abbaspour Kasgari, Haadi Majidi, et al.
Iranian Journal of Pharmaceutical Research : IJPR|April 12, 2021
Evaluating the Effect of Dexmedetomidine on Hemodynamic Status of Patients with Septic Shock Admitted to Intensive Care Unit: A Single-Blind Randomized Controlled TrialShayesteh Gheibi, Shahram Ala, Fatemeh Heydari, et al.
Pacing and Clinical Electrophysiology : PACE|May 14, 2026
Short-Term, Weight-Adjusted Colchicine to Prevent Post-CABG Arrhythmias: A Randomized, Double-Blind, Controlled TrialAmir Hassan Farzaneh, Hamideh Abbaspour, Valiollah Habibi, et al.
Journal of Research in Pharmacy Practice|April 25, 2025
Evaluation of the Effect of N-acetylcysteine in the Prevention of Colistin Nephrotoxicity in Critically Ill Patients: A Randomized Controlled TrialAmir Mohammad Shabani, Ahmad Alikhani, Fatemeh Heydari, et al.
Biomed Research International|July 12, 2021
Studying the Effect of Taking Statins before Infection in the Severity Reduction of COVID-19 with Machine LearningAlireza Davoudi, Mohsen Ahmadi, Abbas Sharifi, et al.
The Journal of Antimicrobial Chemotherapy|October 16, 2020
Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysisBryony Simmons, Hannah Wentzel, Sara Mobarak, et al.
Iranian Journal of Pharmaceutical Research : IJPR|February 23, 2022
Comparison of the Efficacy and Safety of Atazanavir/Ritonavir Plus Hydroxychloroquine with Lopinavir/Ritonavir Plus Hydroxychloroquine in Patients with Moderate COVID-19, A Randomized, Double-blind Clinical TrialZahra Nekoukar, Shahram Ala, Siavash Moradi, et al.
The Journal of Antimicrobial Chemotherapy|August 20, 2020
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trialHamideh Abbaspour Kasgari, Siavash Moradi, Amir Mohammad Shabani, et al.
Pageof 2